Newbridge Financial Services Group’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $116 | Hold |
24
| – | – | ﹤0.01% | 1279 |
|
|
2025
Q1 | $35 | Hold |
24
| – | – | ﹤0.01% | 1027 |
|
|
2024
Q4 | $46 | Hold |
24
| – | – | ﹤0.01% | 1119 |
|
|
2024
Q3 | $77 | Sell |
24
-1
| -4% | -$3 | ﹤0.01% | 642 |
|
|
2024
Q2 | $176 | Hold |
25
| – | – | ﹤0.01% | 1048 |
|
|
2024
Q1 | $456 | Hold |
25
| – | – | ﹤0.01% | 1097 |
|
|
2023
Q4 | $269 | Hold |
25
| – | – | ﹤0.01% | 1070 |
|
|
2023
Q3 | $501 | Sell |
25
-14
| -36% | -$281 | ﹤0.01% | 1204 |
|
|
2023
Q2 | $2.96K | Hold |
39
| – | – | ﹤0.01% | 1093 |
|
|
2023
Q1 | $3.65K | Hold |
39
| – | – | ﹤0.01% | 1121 |
|
|
2022
Q4 | $3.77K | Hold |
39
| – | – | ﹤0.01% | 1113 |
|
|
2022
Q3 | $10K | Hold |
39
| – | – | 0.01% | 892 |
|
|
2022
Q2 | $7K | Hold |
39
| – | – | ﹤0.01% | 952 |
|
|
2022
Q1 | $4K | Hold |
39
| – | – | ﹤0.01% | 1159 |
|
|
2021
Q4 | $6K | Hold |
39
| – | – | ﹤0.01% | 1042 |
|
|
2021
Q3 | $11K | Hold |
39
| – | – | 0.01% | 856 |
|
|
2021
Q2 | $15K | Hold |
39
| – | – | 0.01% | 864 |
|
|
2021
Q1 | $21K | Hold |
39
| – | – | 0.02% | 683 |
|
|
2020
Q4 | $15K | Hold |
39
| – | – | 0.01% | 620 |
|
|
2020
Q3 | $15K | Buy |
+39
| New | +$15K | 0.01% | 583 |
|